David R. Mole
Impact in
- Cancer Research top 0.02%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Molecular Biology top 0.5%
- Mitochondrial Function and Pathology
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
Papers in
-
- Cancer, Hypoxia, and Metabolism 49
- Cancer-related molecular mechanisms research 9
-
- RNA modifications and cancer 23
- Epigenetics and DNA Methylation 19
- Mitochondrial Function and Pathology 6
- Metabolism, Diabetes, and Cancer 5
- Co-authors
- Peter J. Ratcliffe (42 shared papers)Christopher W. Pugh (17 shared papers)Patrick H. Maxwell (6 shared papers)Panu Jaakkola (3 shared papers)Christopher J. Schofield (7 shared papers)Ya‐Min Tian (8 shared papers)Michael Wilson (2 shared papers)Mridul Mukherji (2 shared papers)
- Journals
- Journal of Biological Chemistry (6 papers)Blood (4 papers)Nature Genetics (3 papers)EMBO Reports (3 papers)Nucleic Acids Research (3 papers)
- Partner nations
- United KingdomSaudi ArabiaGermany
In The Last Decade
David R. Mole
67 papers receiving 14.4k citations
David R. Mole's Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 9.7k
- Molecular Biology 8.6k
- Biochemistry 744
- Aging 146
- Genetics 2.1k
Countries citing papers authored by David R. Mole
This map shows the geographic impact of David R. Mole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Mole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Mole more than expected).
Fields of papers citing papers by David R. Mole
This network shows the impact of papers produced by David R. Mole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Mole. The network helps show where David R. Mole may publish in the future.
Co-authors
The 25 scholars most cited alongside David R. Mole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation Hit paper breakdown → | 2001 | 4714 |
| 2 | C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation Hit paper breakdown → | 2001 | 2838 |
| 3 | Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein Hit paper breakdown → | 2000 | 921 |
| 4 | HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability Hit paper breakdown → | 2005 | 775 |
| 5 | High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq Hit paper breakdown → | 2011 | 579 |
| 6 | Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts Hit paper breakdown → | 2009 | 480 |
| 7 | 2002 | 400 | |
| 8 | Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer Hit paper breakdown → | 2015 | 289 |
| 9 | 2008 | 269 | |
| 10 | Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival Hit paper breakdown → | 2014 | 268 |
| 11 | 2009 | 213 | |
| 12 | 2018 | 148 | |
| 13 | 2013 | 140 | |
| 14 | 2013 | 137 | |
| 15 | 2014 | 132 | |
| 16 | 2011 | 131 | |
| 17 | 2015 | 130 | |
| 18 | 2003 | 129 | |
| 19 | 2004 | 127 | |
| 20 | 2012 | 124 |
About David R. Mole
David R. Mole is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Physiology and Genetics, having authored 71 papers that have together received 14.7k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (49 papers), RNA modifications and cancer (23 papers), Epigenetics and DNA Methylation (19 papers), Cancer-related molecular mechanisms research (9 papers), High Altitude and Hypoxia (7 papers), Mitochondrial Function and Pathology (6 papers), Renal cell carcinoma treatment (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Cancer Research (9.7k citations), Molecular Biology (8.6k citations), Biochemistry (744 citations), Aging (146 citations) and Genetics (2.1k citations). David R. Mole has collaborated with scholars based in United Kingdom, Saudi Arabia and Germany. Frequent co-authors include Peter J. Ratcliffe, Christopher W. Pugh, Patrick H. Maxwell, Panu Jaakkola, Christopher J. Schofield, Ya‐Min Tian, Michael Wilson, Mridul Mukherji, Alex von Kriegsheim and Simon J. Gaskell. Their work appears in journals such as Journal of Biological Chemistry, Blood, Nature Genetics, EMBO Reports and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.